Stockscreener 앱 받기
51.32
1.50%
0.76
시간 외 거래:
52.56
1.24
+2.42%
전일 마감가:
$50.56
열려 있는:
$50.39
하루 거래량:
654.75K
Relative Volume:
0.76
시가총액:
$3.07B
수익:
$574.50M
순이익/손실:
$-78.58M
주가수익비율:
-855.33
EPS:
-0.06
순현금흐름:
$1.58M
1주 성능:
-3.81%
1개월 성능:
+16.03%
6개월 성능:
+12.17%
1년 성능:
-11.49%
1일 변동 폭
$49.75
$52.59
1주일 범위
$49.11
$53.67
52주 변동 폭
$36.73
$67.13
Inari Medical Inc Stock (NARI) Company Profile
명칭
Inari Medical Inc
전화
949-923-4747
주소
6001 OAK CANYON, SUITE 100, IRVINE, CA
NARI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| NARI | 51.32 | 3.07B | 574.50M | -78.58M | 1.58M | -0.06 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Inari Medical Inc Stock (NARI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-18 | 개시 | Stifel | Hold |
| 2024-09-03 | 개시 | Leerink Partners | Market Perform |
| 2024-08-09 | 개시 | Deutsche Bank | Buy |
| 2024-07-25 | 개시 | William Blair | Outperform |
| 2024-07-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-02-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-01-23 | 개시 | Needham | Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-09-29 | 개시 | Berenberg | Buy |
| 2022-09-13 | 개시 | Truist | Hold |
| 2022-06-21 | 개시 | Piper Sandler | Overweight |
| 2022-03-23 | 재개 | BofA Securities | Buy |
| 2020-12-15 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2020-11-18 | 개시 | BTIG Research | Buy |
| 2020-10-29 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-09-28 | 개시 | SVB Leerink | Outperform |
| 2020-06-19 | 개시 | Canaccord Genuity | Buy |
| 2020-06-16 | 개시 | BofA/Merrill | Neutral |
| 2020-06-16 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-06-16 | 개시 | Wells Fargo | Equal Weight |
모두보기
Inari Medical Inc 주식(NARI)의 최신 뉴스
First Week of January 2025 Options Trading For Inari Medical (NARI) - Nasdaq
Inari Medical, Inc. (NASDAQ:NARI) Receives $58.89 Average Target Price from Analysts - MarketBeat
10,369 Shares in Inari Medical, Inc. (NASDAQ:NARI) Acquired by Aigen Investment Management LP - MarketBeat
Trend Tracker for (NARI) - Stock Traders Daily
Fiera Capital Corp Sells 19,821 Shares of Inari Medical, Inc. (NASDAQ:NARI) - MarketBeat
NARIInari Medical, Inc. Latest Stock News & Market Updates - StockTitan
Is Inari Medical (NARI) Trading at an Attractive Valuation? - Yahoo Finance
Inari Medical, Inc. (NASDAQ:NARI) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable - Simply Wall St
Financial Enhancement Group LLC Acquires Shares of 28,002 Inari Medical, Inc. (NASDAQ:NARI) - MarketBeat
Inari Medical to Participate in the Jefferies London Healthcare Conference - The Manila Times
Inari Medical to Present at Jefferies London Healthcare Conference 2024 | NARI Stock News - StockTitan
Inari Medical FY2025 EPS Estimate Boosted by William Blair - MarketBeat
(NARI) Proactive Strategies - Stock Traders Daily
Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday - MSN
Inari medical director William Hoffman sells $2 million in stock By Investing.com - Investing.com Canada
Inari Medical CEO Andrew Hykes sells $150,000 in stock - Investing.com India
Inari Medical CEO Andrew Hykes sells $150,000 in stock By Investing.com - Investing.com Canada
Director William Hoffman Sells 40,000 Shares of Inari Medical In - GuruFocus.com
Inari medical director William Hoffman sells $2 million in stock - Investing.com
Inari Medical shares hold as Canaccord affirms Buy rating By Investing.com - Investing.com Australia
Leerink Partnrs Expects Stronger Earnings for Inari Medical - MarketBeat
Inari Medical shares hold as Canaccord affirms Buy rating - Investing.com
Piper Sandler raises Inari Medical stock target on strong Q3 revenue - Investing.com Australia
Inari Medical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St
Inari Medical FY2026 EPS Estimate Cut by Leerink Partnrs - MarketBeat
Inari Medical Q3 Earnings Miss Estimates, Revenues Increase Y/Y - MSN
BTIG keeps Buy rating on Inari shares, upbeat following beat-and-raise Q3 - Investing.com Canada
Inari Medical Inc (NARI) Q3 2024 Earnings: Revenue Hits $153M, E - GuruFocus.com
Inari Medical Q3 2024 Earnings Preview - MSN
Inari Medical stock target boosted on profit beat, Hold rating upheld By Investing.com - Investing.com South Africa
BTIG keeps Buy rating on Inari shares, upbeat following beat-and-raise Q3 By Investing.com - Investing.com South Africa
Inari Medical stock price target raised on strong growth outlook By Investing.com - Investing.com South Africa
Piper Sandler raises Inari Medical stock target on strong Q3 revenue By Investing.com - Investing.com South Africa
Inari Medical, Hertz Global, Fastly, and Ryvyl Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information - GlobeNewswire
Inari Medical, Hertz Global, Fastly, and Ryvyl Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information - GlobeNewswire Inc.
Earnings call: Inari Medical posts record revenue in Q3, aims for profitability By Investing.com - Investing.com South Africa
Earnings call: Inari Medical posts record revenue in Q3, aims for profitability - Investing.com Australia
Inari Medical Breaks Above 200-Day Moving AverageBullish for NARI - Nasdaq
Inari Medical Inc (NARI) Q3 2024 Earnings Call Highlights: Record Revenue and Raised Guidance ... - Yahoo Finance
Inari Medical Inc (NARI) Q3 2024 Earnings Call Highlights: Recor - GuruFocus.com
PEERLESS Results Show Superiority of FlowTriever® Compared - GlobeNewswire
PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism - StockTitan
Inari Medical (NASDAQ:NARI) Shares Gap Up Following Analyst Upgrade - MarketBeat
Inari Medical, Inc. (NASDAQ:NARI) Q3 2024 Earnings Call Transcript - MSN
Inari Medical stock target boosted on profit beat, Hold rating upheld - Investing.com
Key Takeaways From Inari Medical Analyst Ratings - Benzinga
Inari Medical stock price target raised on strong growth outlook - Investing.com India
Needham & Company LLC Reiterates Hold Rating for Inari Medical (NASDAQ:NARI) - MarketBeat
Truist Financial Boosts Inari Medical (NASDAQ:NARI) Price Target to $50.00 - MarketBeat
Inari Medical revenue jumps 21% to USD 153 in Q3 2024 - Medical Buyer
Inari Medical, Inc. (NARI) Reports Q3 Loss, Tops Revenue Estimates - MSN
Inari Medical Inc (NARI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
0.43%
자본화:
|
볼륨(24시간):